Additionally, in patients diagnosed with the CCC, the HLA types HLA-C*07:04 or HLA-DQB1*03:03 were shown to be significantly linked to ME/CFS status when using the CCC (89)
Individuals taking Wegovy were reported to lose an average of ~35 lbs (or ~15% of their body weight) during the course of the study while individuals in the placebo group lost an average of 6 lbs (or ~2.5% body weight)
Clinical evidence shows that GLP1R agonists not only improve glycemic control but also exert beneficial effects on body weight and the cardiovascular system, as confirmed in large-scale trials of agents such as Liraglutide (Marso et al., 2016), Dulaglutide (Gerstein et al., 2019), and Semaglutide (Lincoff et al., 2023)
Starting the conversation with a clinician about what happens next before the first injection is an important part of an informed decision
Occasional hunger can reflect everyday needs for energy or the body adapting to a lower calorie intake